HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher A Darlow Selected Research

flomoxef

6/2022Correction to: Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales.
1/2022Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.
1/2022Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales.
1/2022Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales-authors' response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher A Darlow Research Topics

Disease

6Neonatal Sepsis
06/2022 - 01/2021
1Infertility (Sterility)
01/2022
1Staphylococcal Infections
08/2017
1Suppuration
08/2017
1Epidural Abscess
08/2017

Drug/Important Bio-Agent (IBA)

4flomoxefIBA
06/2022 - 01/2022
2FosfomycinFDA Link
01/2022 - 01/2021
2Ampicillin (Omnipen)FDA LinkGeneric
09/2021 - 01/2021
2Gentamicins (Gentamicin)FDA LinkGeneric
09/2021 - 01/2021
2Anti-Bacterial Agents (Antibiotics)IBA
09/2021 - 01/2021
1Pharmaceutical PreparationsIBA
01/2022
1EnzymesIBA
01/2021
1Amikacin (A.M.K)FDA LinkGeneric
01/2021
1AminoglycosidesIBA
01/2021
1Floxacillin (Flucloxacillin)IBA
08/2017
1Clindamycin (Cleocin)FDA LinkGeneric
08/2017